Validation of a Mucosal IgA Assay for SARS-CoV-2

Mucosal immunity, including antibodies like immunoglobulin A (IgA), function as the body’s first line of defense in the respiratory tract, particularly against viruses. An anti-rS protein IgA enzyme-linked immunosorbent assay (ELISA) was developed using the Omicron XBB.1.5 subvariant of SARS-CoV-2 a...

Full description

Bibliographic Details
Published in:Microorganisms
Main Authors: Mingzhu Zhu, Edmond Massuda, Shane Cloney-Clark, Urvashi Patel, Anand Parekh, Andrew Gorinson, Andrew Klindworth, Ali Ahmadi, Miranda R. Cai, Chijioke Bennett, Raj Kalkeri, Joyce S. Plested
Format: Article
Language:English
Published: MDPI AG 2026-05-01
Subjects:
COVID-19
immunogenicity
SARS-CoV-2
assay validation
correlate of protection
Omicron XBB.1.5
Online Access:https://www.mdpi.com/2076-2607/14/5/1154

Internet

https://www.mdpi.com/2076-2607/14/5/1154

Similar Items